
Immediate DAA treatment, syringe services, and society advocacy are key to eliminating the hepatitis C virus (HCV) among people who use drugs.

Norah Terrault, MD, MPH, is a professor of medicine and chief of the division of gastrointestinal and liver diseases at the University of Southern California.

Immediate DAA treatment, syringe services, and society advocacy are key to eliminating the hepatitis C virus (HCV) among people who use drugs.